| 17beta-estradiol | decreases expression | ISO | RGD:1354371 | 6480464 | Estradiol results in decreased expression of ARHGDIA mRNA | CTD | PMID:15757668 PMID:15159206 |
| 17beta-estradiol | decreases expression | ISO | RGD:1354371 | 6480464 | Estradiol results in decreased expression of ARHGDIA mRNA | CTD | PMID:15159206 PMID:15757668 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1552296 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGDIA mRNA | CTD | PMID:19465110 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of ARHGDIA mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of ARHGDIA mRNA | CTD | PMID:21346803 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1354371 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ARHGDIA mRNA | CTD | PMID:12419474 |
| ampicillin | increases expression | ISO | RGD:1354371 | 6480464 | Ampicillin results in increased expression of ARHGDIA mRNA | CTD | PMID:21632981 |
| arachidonic acid | increases expression | ISO | RGD:1354371 | 6480464 | Arachidonic Acid results in increased expression of ARHGDIA mRNA | CTD | PMID:16704987 |
| bathocuproine disulfonic acid | multiple interactions | ISO | RGD:1354371 | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ARHGDIA mRNA | CTD | PMID:15477007 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1354371 | 6480464 | Benzo(a)pyrene results in decreased expression of ARHGDIA mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1354371 | 6480464 | Benzo(a)pyrene results in increased expression of ARHGDIA protein | CTD | PMID:22138271 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1354371 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of ARHGDIA protein] | CTD | PMID:22138271 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552296 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to ARHGDIA promoter] | CTD | PMID:19654925 |
| busulfan | multiple interactions | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] | CTD | PMID:17264767 |
| busulfan | affects response to substance | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the susceptibility to Busulfan | CTD | PMID:17264767 |
| cadmium atom | increases expression | ISO | RGD:1354371 | 6480464 | Cadmium results in increased expression of ARHGDIA protein | CTD | PMID:16440303 |
| cadmium dichloride | increases expression | ISO | RGD:1354371 | 6480464 | Cadmium Chloride results in increased expression of ARHGDIA protein | CTD | PMID:16440303 |
| cadmium dichloride | decreases expression | ISO | RGD:1354371 | 6480464 | Cadmium Chloride results in decreased expression of ARHGDIA mRNA | CTD | PMID:12760830 |
| choline | multiple interactions | ISO | RGD:1552296 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA | CTD | PMID:20938992 |
| coumestrol | multiple interactions | ISO | RGD:1354371 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA | CTD | PMID:19167446 |
| daidzein | decreases expression | ISO | RGD:1354371 | 6480464 | daidzein results in decreased expression of ARHGDIA mRNA | CTD | PMID:15757668 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1354371 | 6480464 | Tetrahydrocannabinol results in increased expression of ARHGDIA protein | CTD | PMID:18163980 |
| desferrioxamine B | decreases expression | ISO | RGD:1354371 | 6480464 | Deferoxamine results in decreased expression of ARHGDIA protein | CTD | PMID:19515424 |
| desferrioxamine B | multiple interactions | ISO | RGD:1354371 | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ARHGDIA protein] | CTD | PMID:19515424 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ARHGDIA mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | decreases expression | ISO | RGD:1354371 | 6480464 | Diethylstilbestrol results in decreased expression of ARHGDIA mRNA | CTD | PMID:15159206 |
| diethylstilbestrol | increases expression | ISO | RGD:1354371 | 6480464 | Diethylstilbestrol results in increased expression of ARHGDIA mRNA | CTD | PMID:15766595 |
| dioxygen | decreases expression | ISO | RGD:1354371 | 6480464 | Oxygen deficiency results in decreased expression of ARHGDIA mRNA | CTD | PMID:17175027 |
| doxorubicin | multiple interactions | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the reaction [Doxorubicin results in increased activity of CASP3 protein] | CTD | PMID:17264767 |
| doxorubicin | affects response to substance | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the susceptibility to Doxorubicin | CTD | PMID:17264767 |
| elemental selenium | increases expression | ISO | RGD:1354371 | 6480464 | Selenium results in increased expression of ARHGDIA mRNA | CTD | PMID:19244175 |
| estriol | decreases expression | ISO | RGD:1354371 | 6480464 | Estriol results in decreased expression of ARHGDIA mRNA | CTD | PMID:15159206 |
| estrone | decreases expression | ISO | RGD:1354371 | 6480464 | Estrone results in decreased expression of ARHGDIA mRNA | CTD | PMID:15159206 |
| ethanol | increases expression | ISO | RGD:1552296 | 6480464 | Ethanol results in increased expression of ARHGDIA mRNA | CTD | PMID:19167417 |
| ferric ammonium citrate | multiple interactions | ISO | RGD:1354371 | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ARHGDIA protein] | CTD | PMID:19515424 |
| folic acid | multiple interactions | ISO | RGD:1552296 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA | CTD | PMID:20938992 |
| fumonisin B1 | increases expression | ISO | RGD:1552296 | 6480464 | fumonisin B1 results in increased expression of ARHGDIA mRNA | CTD | PMID:16221962 |
| genistein | decreases expression | ISO | RGD:1354371 | 6480464 | Genistein results in decreased expression of ARHGDIA mRNA | CTD | PMID:15757668 PMID:15159206 |
| genistein | decreases expression | ISO | RGD:1354371 | 6480464 | Genistein results in decreased expression of ARHGDIA mRNA | CTD | PMID:15159206 PMID:15757668 |
| hydrogen peroxide | decreases expression | ISO | RGD:1354371 | 6480464 | Hydrogen Peroxide results in decreased expression of ARHGDIA mRNA | CTD | PMID:12419474 |
| hydroquinone | affects expression | ISO | RGD:1354371 | 6480464 | hydroquinone affects the expression of ARHGDIA protein | CTD | PMID:17181942 |
| L-ascorbic acid | increases expression | ISO | RGD:1552296 | 6480464 | Ascorbic Acid results in increased expression of ARHGDIA mRNA | CTD | PMID:22139585 |
| L-methionine | multiple interactions | ISO | RGD:1354371 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of ARHGDIA protein] | CTD | PMID:22138271 |
| L-methionine | multiple interactions | ISO | RGD:1552296 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGDIA mRNA | CTD | PMID:20938992 |
| lead(0) | decreases expression | ISO | RGD:1354371 | 6480464 | Lead results in decreased expression of ARHGDIA mRNA | CTD | PMID:19921347 |
| lovastatin | increases expression | ISO | RGD:1552296 | 6480464 | Lovastatin results in increased expression of ARHGDIA mRNA | CTD | PMID:20493250 |
| manganese atom | decreases expression | ISO | RGD:1354371 | 6480464 | Manganese results in decreased expression of ARHGDIA mRNA | CTD | PMID:17175027 |
| manganese(0) | decreases expression | ISO | RGD:1354371 | 6480464 | Manganese results in decreased expression of ARHGDIA mRNA | CTD | PMID:17175027 |
| manganese(II) chloride | decreases expression | ISO | RGD:1354371 | 6480464 | manganese chloride results in decreased expression of ARHGDIA mRNA | CTD | PMID:17175027 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of ARHGDIA protein | CTD | PMID:19826936 |
| methotrexate | affects response to substance | ISO | RGD:1354371 | 6480464 | ARHGDIA protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 |
| oxaliplatin | increases expression | ISO | RGD:1354371 | 6480464 | oxaliplatin results in increased expression of ARHGDIA mRNA | CTD | PMID:17762391 |
| paclitaxel | multiple interactions | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the reaction [Paclitaxel results in increased activity of CASP3 protein] | CTD | PMID:17264767 |
| paclitaxel | affects response to substance | ISO | RGD:1354371 | 6480464 | ARHGDIA mRNA affects the susceptibility to Paclitaxel | CTD | PMID:17264767 |
| paracetamol | affects expression | ISO | RGD:1552296 | 6480464 | Acetaminophen affects the expression of ARHGDIA mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1354371 | 6480464 | Acetaminophen results in decreased expression of ARHGDIA mRNA | CTD | PMID:22230336 |
| paraoxon | increases expression | ISO | RGD:1354371 | 6480464 | Paraoxon results in increased expression of ARHGDIA protein | CTD | PMID:20931991 |
| phenobarbital | multiple interactions | ISO | RGD:1552296 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ARHGDIA mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1552296 | 6480464 | Phenobarbital results in increased expression of ARHGDIA mRNA | CTD | PMID:19482888 |
| progesterone | decreases expression | ISO | RGD:1354371 | 6480464 | Progesterone results in decreased expression of ARHGDIA mRNA | CTD | PMID:18070364 |
| pyrogallol | increases expression | ISO | RGD:1552296 | 6480464 | Pyrogallol results in increased expression of ARHGDIA mRNA | CTD | PMID:20362636 |
| selenium atom | increases expression | ISO | RGD:1354371 | 6480464 | Selenium results in increased expression of ARHGDIA mRNA | CTD | PMID:19244175 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1354371 | 6480464 | tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA | CTD | PMID:12419474 |